Castleman disease in a pediatric liver transplant recipient: A case report and literature review

Pediatric Transplantation

Volumn 16, Issue 6, 2012, Pages

  Bonatti, Hugo J R ^a   Axt, Jason ^a   Hunter, Ellen Bailey ^a   Lott, Sarah Louise ^a   Frangoul, Haydar ^a   Gillis, Lynette ^a   Correa, Hernan ^a   Kelly, Beau ^a,b  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

human herpesvirus 8; pediatric liver transplantation; post transplant lymphoproliferative disorders

Indexed keywords

4 PHENYLBUTYRIC ACID; ALPHA FETOPROTEIN; AMMONIA; BASILIXIMAB; CD20 ANTIGEN; CITRULLINE; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; TRYPTOPHAN; VALGANCICLOVIR;

AMMONIA BLOOD LEVEL; ANEMIA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; AXILLARY LYMPH NODE; B LYMPHOCYTE; CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY; CASE REPORT; CD3+ T LYMPHOCYTE; CELL POPULATION; CERVICAL LYMPHADENOPATHY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIET THERAPY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTRACORPOREAL OXYGENATION; FEVER; FLOW CYTOMETRY; GENETIC ANALYSIS; GERMINAL CENTER; GRAFT RECIPIENT; GROWTH RETARDATION; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; HYPERAMMONEMIA; HYPERURICEMIA; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTRAUTERINE GROWTH RETARDATION; LETHARGY; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPH NODE; LYMPH NODE BIOPSY; LYMPHADENECTOMY; LYMPHADENOPATHY; MALE; MATERNAL SERUM; PARAAORTIC LYMPH NODE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; QUALITATIVE DIAGNOSIS; RENAL REPLACEMENT THERAPY; REVIEW; SPLENOMEGALY; THORAX WALL;

ADOLESCENT; ADULT; ANTIGENS, CD20; ANTIGENS, CD3; B-LYMPHOCYTES; GIANT LYMPH NODE HYPERPLASIA; GRAFT SURVIVAL; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; LIVER FAILURE; LIVER TRANSPLANTATION; LYMPHATIC DISEASES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SIROLIMUS; SPLENOMEGALY; T-LYMPHOCYTES; TACROLIMUS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84864629475     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01570.x     Document Type: Review

References (28)

1. Casper C,. The aetiology and management of Castleman disease at 50 years: Translating pathophysiology to patient care. Br J Haematol 2005: 129: 3-17. (Pubitemid 40524047)
2. Cronin DM, Warnke RA,. Castleman disease: An update on classification and the spectrum of associated lesions. Adv Anat Pathol 2009: 16: 236-246.
3. Waterston A, Bower M,. Fifty years of multicentric Castleman's disease. Acta Oncol 2004: 43: 698-704. (Pubitemid 40066010)
4. Cagirgan S, Cirit M, Ok E, et al., Castleman's disease in a renal allograft recipient. Nephron 1997: 76: 352-353. (Pubitemid 27296541)
5. Gaitonde S, Vidanovic V, Ni H,. Concomitant and fatal HHV-8 + multicentric Castleman's disease and Kaposi's sarcoma in the same lymph node of an HIV- liver transplant patient. Histopathology 2007: 50: 954-958.
6. Lebbe C,. [HHV-8 infection in renal transplantation]. Nephrologie 2001: 22: 313-315.
7. Hille JJ, Webster-Cyriaque J, Palefski JM, Raab-Traub N,. Mechanisms of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions. Oral Dis 2002: 8 (Suppl. 2): 161-168. (Pubitemid 41758957)
8. Boeckle E, Boesmueller C, Wiesmayr S, et al., Kaposi sarcoma in solid organ transplant recipients: A single center report. Transplant Proc 2005: 37: 1905-1909. (Pubitemid 40790865)
9. Hengge UR, Ruzicka T, Tyring SK, et al., Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: Pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2002: 2: 344-352. (Pubitemid 34595974)
10. Hengge UR, Ruzicka T, Tyring SK, et al., Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2002: 2: 281-292. (Pubitemid 34464739)
11. Lebbe C, Legendre C, Frances C,. Kaposi sarcoma in transplantation. Transplant Rev (Orlando) 2008: 22: 252-261.
12. Al Otaibi T, Al Sagheir A, Ludwin D, Meyer R,. Post renal transplant Castleman's disease resolved after graft nephrectomy: A case report. Transplant Proc 2007: 39: 1276-1277. (Pubitemid 46764896)
13. Theate I, Michaux L, Squifflet JP, Martin A, Raphael M,. Human herpesvirus 8 and Epstein-Barr virus-related monotypic large B-cell lymphoproliferative disorder coexisting with mixed variant of Castleman's disease in a lymph node of a renal transplant recipient. Clin Transplant 2003: 17: 451-454. (Pubitemid 37236119)
14. Mandel C, Silberstein M, Hennessy O,. Case report: Fatal pulmonary Kaposi's sarcoma and Castleman's disease in a renal transplant recipient. Br J Radiol 1993: 66: 264-265. (Pubitemid 23096982)
15. DiNardo CD, Tsai DE,. Treatment advances in posttransplant lymphoproliferative disease. Curr Opin Hematol 2010: 17: 368-374.
16. Gross TG, Savoldo B, Punnett A,. Posttransplant lymphoproliferative diseases. Pediatr Clin North Am 2010: 57: 481-503.
17. Serraino D, Toma L, Andreoni M, et al., A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. Eur J Epidemiol 2001: 17: 871-876. (Pubitemid 34602331)
18. Diociaiuti A, Nanni G, Cattani P, et al., HHV8 in renal transplant recipients. Transpl Int 2000: 13 (Suppl. 1): S410-S412.
19. Matusushima AY, Strauchen JA, Lee G, et al., Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol 1999: 23: 1393.
20. Concato C, Diociaiuti A, Parisi F, et al., Human herpesvirus-8 serology in pediatric organ transplantation. Transplant Proc 2008: 40: 3683-3684.
21. Luppi M, Barozzi P, Rasini V, Torelli G,. HHV-8 infection in the transplantation setting: A concern only for solid organ transplant patients? Leuk Lymphoma 2002: 43: 517-522. (Pubitemid 34232918)
22. Bonatti H, Aigner F, De Clercq E, et al., Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. Transpl Int 2007: 20: 238-246.
23. Ruozi B, Riva G, Belletti D, et al., Cidofovir-loaded liposomes: In vitro study against primary effusion lymphoma. Eur J Pharm Sci 2010: 41: 254-264. Epub 2010 Jul 1.
24. Barozzi P, Riva G, Vallerini D, et al., Indirect antitumor effects of mammalian target of rapamycin inhibitors against Kaposi sarcoma in transplant patients. Transplantation 2009: 88: 597-598.
25. Campeau PM, Pivalizza PJ, Miller G, et al., Early orthotopic liver transplantation in urea cycle defects: Follow up of a developmental outcome study. Mol Genet Metab 2010: 100: S84-S87.
26. Manuelli M, De Luca L, Iaria G, et al., Conversion to rapamycin immunosuppression for malignancy after kidney transplant. Transplant Proc 2010: 42: 1314-1316.
27. Lim EJ, Crowley P, Mitchell CA, Angus PW,. Post-liver transplantation multicentric Castleman disease treated with valganciclovir and weaning of immunosuppression. Am J Transplant 2011: 11: 169-172.
28. Crumpacker CS,. Valganciclovir and human herpesvirus-8. J Infect Dis 2008: 198: 6-7. (Pubitemid 351920281)